Dr Jeff Sharman is curious to understand what people know / think they know about the new drugs Ibrutinib, Idelalisib and obinutuzumab. His latest blog was a 10 question survey (now closed) to gain CLL community feedback, the results of which he plans to use to help shape future his blog posts.
You can keep an eye on his site for new articles inspired by the survey responses here:
Neil
Photo: Common Fringe Myrtle in flower - but how could you call this common?